Cargando…

Panniculitis as the Transformed Cutaneous Manifestation of Refractory Dermatomyositis with Successful Management with Tofacitinib

Detalles Bibliográficos
Autores principales:	Rathore, Upendra, Nigam, Neha, Aggarwal, Amita, Gupta, Latika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727465/ https://www.ncbi.nlm.nih.gov/pubmed/36531418 http://dx.doi.org/10.31138/mjr.33.3.380

Ejemplares similares

Panniculitis associated with amyopathic dermatomyositis
por: Azevedo, Paula de Oliveira, et al.
Publicado: (2018)

Mechanic’s Hand Heralding Relapse in an Indian Adolescent with Anti-MDA5 Positive Juvenile Dermatomyositis
por: Ganatra, Keya, et al.
Publicado: (2022)

Refractory Lupus Panniculitis Treated Successfully with Rituximab: Two Cases
por: Gupta, Partisha, et al.
Publicado: (2020)

Panniculitis as a unique manifestation of Rosai-Dorfman disease
por: Huang, Lining, et al.
Publicado: (2022)

Panniculitis as an Initial Presentation of Dermatomyositis: A Case Report
por: Bisht, Anjal, et al.
Publicado: (2020)

Cutaneous Manifestation of Alpha-1 Antitrypsin Deficiency: A Case of Panniculitis
por: Lopes, Sofia, et al.
Publicado: (2018)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis
por: Hirata, Chika, et al.
Publicado: (2022)

68-year old woman with refractory cutaneous dermatomyositis
por: Antonopoulos, Ioannis, et al.
Publicado: (2018)

Successful treatment of refractory IgA vasculitis with tofacitinib
por: Xu, Yi-Fei, et al.
Publicado: (2022)

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China
por: Zhang, Junmei, et al.
Publicado: (2023)

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies
por: Okiyama, Naoko, et al.
Publicado: (2019)

Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis
por: Castillo, Rochelle L., et al.
Publicado: (2021)

Cutaneous Manifestations and Their Corresponding Dermoscopic Features in Patients with Dermatomyositis
por: Pozharashka, Joana, et al.
Publicado: (2022)

Wolf’s Panniculitis
por: Chokoeva, Anastasiya Atanasova, et al.
Publicado: (2017)

Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report
por: Zhu, Kai-Jun, et al.
Publicado: (2021)

Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib
por: Jia, Ertao, et al.
Publicado: (2020)

Palmoplantar keratoderma as the preceding cutaneous manifestation of juvenile-onset dermatomyositis
por: Patra, Pratap Kumar, et al.
Publicado: (2022)

Lupus panniculitis: a rare bilateral and symmetrical manifestation of cutaneous lupus erythematosus in an adolescent girl
por: Sari, Agnes Rosarina Prita, et al.
Publicado: (2022)

Successful Treatment of Cutaneous Lesions of Dermatomyositis with Topical Pimecrolimus
por: Kim, Ji Eun, et al.
Publicado: (2011)

Successful Use of Tofacitinib in Refractory Takayasu Arteritis: A Case Series
por: MV, Prakashini, et al.
Publicado: (2023)

Panniculitis – A Rare Manifestation of Acute Pancreatitis
por: Neves, Zélia, et al.
Publicado: (2015)

Necrotizing Panniculitis as an Uncommon Manifestation of Acute Pancreatitis
por: Bruno, Cosimo Marcello, et al.
Publicado: (2017)

Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations
por: Habe, Koji, et al.
Publicado: (2019)

Fashionably Late: A Case of Delayed Cutaneous Manifestations in Juvenile Dermatomyositis
por: Antoine, Maya, et al.
Publicado: (2018)

Panniculitis Is an Important Feature of Cutaneous Leishmaniasis Pathology
por: Sharquie, Khalifa E., et al.
Publicado: (2012)

Cutaneous Angiosarcoma Mimicking Panniculitis in the Lower Extremities
por: Ertekin, Sumeyre Seda, et al.
Publicado: (2017)

Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody
por: Kishida, Dai, et al.
Publicado: (2021)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

An Unusual Presentation of Mesenteric Panniculitis
por: Ferrari, Teresa Cristina A., et al.
Publicado: (2008)

Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib
por: Luo, Man, et al.
Publicado: (2022)

COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis
por: Pakhchanian, Haig, et al.
Publicado: (2022)

Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
por: Yang, Qiao, et al.
Publicado: (2018)

Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
por: Shahriari, Neda, et al.
Publicado: (2022)

Coexistence of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Dermatomyositis in a 12-Year-Old Boy
por: Wei, Ruoqu, et al.
Publicado: (2023)

LUPUS PANNICULITIS AS AN INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS
por: Patel, Raksha M, et al.
Publicado: (2010)

Systemic sclerosis presenting as lobular panniculitis
por: Binesh, V. G., et al.
Publicado: (2012)

VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib
por: Fahmy, Lauren M., et al.
Publicado: (2023)

Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_376t7383jhcfjuf3tnm6qpek79